MSSP and LEAD Participants: Why CMS’s Proposed MOD2 Replacement for G2211 Deserves Your Attention

Let’s start with the number that will get everyone’s attention: 32%.

CMS proposes increasing payment for certain office and outpatient E/M visits by 32% when an eligible practitioner participating in the Medicare Shared Savings Program or the LEAD Model uses a new modifier.

That kind of percentage makes its way into an executive meeting before anyone has finished reading the rest of the rule.

But we want you to pause before treating MOD2 as a straightforward payment opportunity.

The additional payment is only one part of the story. For Shared Savings Program ACOs, CMS also proposes including claims submitted with MOD2 in beneficiary assignment calculations, historical benchmark expenditures, and performance-year expenditures.

So, yes, MOD2 could increase practice-level payment.

It could also move through the ACO’s financial methodology in ways that deserve careful modeling.

That makes MOD2 more than a coding change. It is potentially a payment, attribution, benchmark, operations, and governance issue packaged inside one modifier.

And because this is CMS, the package doesn't come with a small instruction card.

First, What Is CMS Actually Proposing?

HCPCS code G2211 is currently an office or outpatient E/M visit complexity add-on code. It is used when a practitioner serves as the continuing focal point for a patient’s care or provides ongoing care for a serious or complex condition.

G2211 is currently paid as a separate flat-rate add-on service.

For 2027, CMS proposes replacing that structure with percentage-based modifiers appended to the associated E/M code.

Here is the proposed structure:

• Placeholder modifier MOD1 would increase payment for the associated E/M service by 16%.

• Placeholder modifier MOD2 would increase payment by 32% when used by an eligible MSSP practitioner or LEAD Participant Provider.

MOD1 and MOD2 are not the final modifier names. They are placeholders. If CMS finalizes the policy, the agency would replace them with two-digit HCPCS modifiers.

The percentage-based structure matters because the payment increase would vary based on the underlying E/M code. Instead of receiving the same flat add-on amount for every eligible visit, the additional payment would rise or fall with the value of the base service.

That may sound like a minor billing detail.

It is not.

Practices will need to understand which E/M services qualify, which practitioners are eligible, how the modifier should be applied and how the resulting claims will be monitored.

This will require more than adding another selection to a billing-system dropdown and hoping everyone uses it responsibly.

Who Would Be Eligible to Use MOD2?

Under the proposal, MOD2 would be available only to:

• Practitioners participating in a Medicare Shared Savings Program ACO

• Participant Providers in a Long-term Enhanced ACO Design Model ACO

That sounds reasonably clear until someone has to configure the billing system.

An ACO may know which organizations are participating. The billing team needs to know which individual practitioners qualify, when their eligibility begins and when it ends.

Those are not always the same dataset.

Before MOD2 could be implemented reliably, the organization would need to reconcile:

• ACO participant TINs

• Individual practitioner NPIs

• Participation effective dates

• Practitioner additions and departures

• Changes of ownership

• Billing-system records

• Credentialing information

• CMS participant files

“The practice is in the ACO” will not be precise enough.

The modifier would be billed at the practitioner and claim level. Eligibility must therefore become a billing control, not a general assumption floating around the organization.

Here Is the Part We Do Not Want You to Miss

CMS proposes allowing eligible MSSP practitioners to use MOD2 for services furnished to all beneficiaries they see, not only beneficiaries assigned to the Shared Savings Program ACO.

CMS proposes the same general approach for LEAD. Eligible Participant Providers could bill MOD2 for services furnished to all beneficiaries, not only beneficiaries aligned to the LEAD ACO.

That significantly changes the analysis.

It means an organization should not begin by looking only at its current assigned or aligned population. The starting point may need to be the practitioner’s broader Medicare E/M volume.

From an operational perspective, this could simplify billing because a practice would not necessarily need to verify ACO assignment or LEAD alignment before using the modifier.

From a financial perspective, however, the policy’s reach could be much broader than leadership initially assumes.

A modifier available across an eligible practitioner’s Medicare population could materially change:

• E/M payment patterns

• Practice revenue

• Coding behavior

• Expenditure data

• Participant comparisons

• Financial projections

If your first calculation includes only assigned beneficiaries, it may answer a much smaller question than the proposal suggests.

The 32% Increase Is Not the Complete Financial Forecast

Let’s say an eligible practice looks at MOD2 and sees additional revenue.

That is understandable. At the claim level, CMS proposes increasing payment for the associated E/M service by 32%.

But an MSSP ACO cannot stop its analysis at the claim level.

CMS states that claims submitted with MOD2 would be included in:

• Beneficiary assignment calculations

• Historical benchmark expenditures

• Performance-year expenditures

That means the same claim producing additional payment for the practice could also enter the ACO’s broader financial calculations.

This creates several questions that finance and ACO leadership should examine together:

• How much additional payment could participating practices receive?

• How much additional expenditure could appear during the performance year?

• How might adoption differ across participant practices?

• Could inconsistent use make participant comparisons less reliable?

• Which MOD2 claims could fall into future historical benchmark periods?

• Could adoption timing create differences between baseline and performance-year spending?

• How should the ACO distinguish additional practice revenue from additional ACO expenditures?

The proposal does not support a simple conclusion that MOD2 will be entirely positive, entirely negative, or automatically neutral for every organization.

The answer will depend on factors such as:

• Participant composition

• Practitioner eligibility

• E/M volume

• Adoption patterns

• Beneficiary assignment

• Historical benchmark years

• Performance periods

• Final CMS methodology

A 32% increase tells you what CMS proposes doing to the associated E/M payment.

It does not tell you the full financial effect on the ACO.

That part still requires math.

MOD2 Could Also Become an Attribution Issue

CMS proposes including MOD2 claims in Shared Savings Program beneficiary assignment calculations.

This is the moment the modifier politely leaves the billing department and introduces itself to network management, analytics, finance and ACO operations.

Beneficiary assignment depends on claims-based relationships and the services included in the assignment methodology. If MOD2 claims become part of those calculations, ACOs will need to understand how modifier use interacts with practitioner relationships and the claims used to assign beneficiaries.

Leadership should be asking:

• Which practitioners are expected to use MOD2?

• Which beneficiaries receive E/M services from those practitioners?

• Are those practitioners correctly represented on the participant list?

• Could changes in claims patterns affect beneficiary assignment?

• How will the ACO identify unexpected attribution movement?

• Who will investigate when the assigned population differs from expectations?

The important lesson is that the claim does not exist in isolation.

If it can affect assignment, it can affect the population the ACO believes it is managing. Once the population changes, other financial and operational assumptions may also need to change.

MSSP and LEAD Leaders Should Not Use the Same Checklist Blindly

MOD2 would be available to eligible practitioners in both MSSP and LEAD.

That does not mean MSSP and LEAD organizations should assume the modifier will move through each program in exactly the same way.

CMS specifically states that, for the Shared Savings Program, MOD2 claims would be included in assignment, historical benchmark expenditures, and performance-year expenditures.

LEAD has its own alignment, benchmark, prospective payment, and settlement methodologies. LEAD organizations may also operate under different capitation arrangements and claims-payment structures.

LEAD participants should therefore watch for final-rule language and additional model guidance addressing:

• Modifier eligibility

• Participant Provider identification

• Claims processing

• Alignment implications

• Benchmark treatment

• Capitation reconciliation

• Interaction with LEAD payment options

• Monitoring and reporting expectations

The proposal gives LEAD participants a reason to prepare.

It does not give them permission to copy the MSSP analysis, change the program name at the top, and call the work complete.

Your Practices Will Need More Than a Coding Memo

If CMS finalizes MOD2, implementation will require several teams to work from the same policy version.

That sounds obvious. In practice, healthcare organizations can produce four versions of the truth from one federal rule.

Here is what should be addressed.

Validate participant eligibility

Confirm which TINs and practitioners qualify, when participation becomes effective, and how roster changes will stop modifier use when a practitioner is no longer eligible.

Configure billing systems

Determine whether practice-management systems can apply the modifier accurately, limit its use to eligible practitioners, and preserve the data needed for monitoring.

Develop documentation guidance

MOD2 should not become an automatic payment button.

Practices will need final CMS guidance explaining when the underlying E/M service and longitudinal-care relationship support modifier use. Translate documentation expectations into clear instructions for clinicians, coders, and auditors.

Educate the right people

Clinicians, coders, billers, compliance teams, finance leaders, and ACO operations staff will each see a different part of the policy.

They need a shared explanation of what the modifier does, who may use it, how it affects payment, and why the ACO is monitoring it.

Monitor utilization

Review modifier use by:

• Practitioner

• Practice

• E/M code level

• Beneficiary population

• Frequency

• Payment effect

• Time period

Monitoring should identify unusual patterns, inconsistent adoption, and use by practitioners whose eligibility cannot be verified.

Model the financial effect

Estimate the potential increase in practice revenue separately from the potential effect on ACO expenditures and benchmark calculations.

Those are connected questions. They are not the same question.

Watch attribution

Determine how the organization will identify and investigate changes in claims-based beneficiary assignment after implementation.

Assign governance

Decide who owns final-policy interpretation, system approval, practitioner eligibility, education, monitoring, and escalation.

If everyone participates but no one owns the outcome, MOD2 will quickly become another regulatory project with an impressive meeting schedule and no clear answer.

What Can ACO Leaders Do Before the Final Rule?

The public-comment period has closed, but that does not mean your organization must sit quietly until CMS publishes the final rule.

You can begin a proposal-based exposure review now without pretending the proposal is final.

Identify potentially eligible practitioners

Reconcile your ACO participant roster with billing, credentialing, and practice-management records.

Do not wait until implementation to discover that each system has a slightly different list.

Establish your E/M baseline

Measure office and outpatient E/M utilization by:

• Eligible practitioner

• E/M code level

• Participating practice

• Beneficiary type

• Time period

This gives your team a defensible starting point for modeling the proposed percentage increase.

Model the 32% scenario

Estimate the potential effect on practice payment and ACO expenditures if CMS finalizes the policy as proposed.

Document the assumptions. When the final rule arrives, your team should know exactly what to update.

Review assignment and alignment implications

Determine which reports and analytics you'll need to identify unexpected population movement or changes in claims patterns.

Assess system readiness

Ask billing and technology vendors whether their systems can support:

• Practitioner-level eligibility

• Effective and termination dates

• Modifier edits

• Exception reporting

• Post-payment monitoring

A vendor saying “we can add the modifier” is only the beginning of the conversation.

Build a provisional governance plan

Assign responsibility for:

• Final-rule review

• Policy interpretation

• Implementation approval

• Roster validation

• Education

• Utilization monitoring

• Audit response

• Escalation

You are not operationalizing a proposed rule.

You are making sure the final rule does not arrive and find your organization introducing finance to billing for the first time.

The Real MOD2 Question

MOD2 could provide additional payment for practitioners carrying the operational burden of longitudinal and accountable care.

That deserves attention.

But I would not let the organization stop at:

How much more could our practices receive?

The stronger question is:

How would this payment policy move through our claims, participant data, beneficiary assignment, benchmark, expenditures, and operating workflows?

That is the analysis MSSP and LEAD leaders need.

CMS may change the modifier names, payment percentages, eligibility rules, claims treatment or operational requirements before the policy is finalized.

That is not a reason to wait.

It is a reason to build a model that clearly separates confirmed facts, proposed policies, and organizational assumptions.

When the final rule arrives, your team should be updating the analysis.

It should not be opening a blank spreadsheet.

Prepare for MOD2 Without Treating It as Final

Chirpy Bird helps MSSP ACOs, LEAD participants, and provider organizations translate proposed payment policy into operational and financial readiness.

We can help your team identify potentially eligible practitioners, model E/M payment and expenditure exposure, reconcile participant data, assess attribution implications, and build an implementation plan you can update when CMS publishes the final rule.

Request a MOD2 Payment and ACO Exposure Review.

Learn more about Chirpy Bird’s ACO services:
https://www.chirpybirdinc.com/acos